Yersinia enterocolitica
LEVELS: Likely to occur: Effective control measures not fully understood; Highly unlikely: No evidence of non-foodborne zoonotic transmission; Unlikely to be effective: One or more pathways of farm-to-farm transmission exist that cannot be controlled by on-farm biosecurity; Easy: Distinct clinical signs and/or existing test(s) available at local/regional laboratory(s); Negligible: No measurable losses; Negligible: Little or no market disruption when disease occurs on one or more farms; Minimal risk: Agent inherently unlikely to develop clinically important resistance to antibacterial or antiviral treatments; Minimal risk: Antibacterial or antiviral treatments rarely occur, or are typically limited to short-course individual animal therapy; Widely available: Multiple effective treatments widely available in the US; No availability: Effective vaccines not currently available in the US (or have not been developed); Not feasible: Eradication extremely unlikely
Criteria Levels
- Foodborne Zoonotic Transmission: Documented foodborne transmission
- Non-Foodborne Zoonotic Transmission: No non-foodborne zoonotic transmission
- Beyond-Farm Spread Potential: Spreads despite standard measures
- Detection Difficulty: Straightforward detection
- Financial Impact - Mortality and Morbidity Costs: Minimal losses
- Financial Impact - Prevention and Control Costs: Little market disruption
- Antimicrobial Resistance - Pathogen Risk: No AMR concern
- Antimicrobial Resistance - Treatment Impact: Minimal AMR concern from disease management
- Treatment Availability: Highly effective treatments readily available
- Vaccine Availability: No effective vaccine
- Eradication Feasibility: Not feasible to eradicate
Detailed Justification
1. Foodborne Zoonotic Transmission
Level: Documented foodborne transmission
Pork is the primary vehicle for human yersiniosis: - "Swine are the primary carrier of Y. enterocolitica and source for human yersiniosis" - "Approximately 75% of human yersiniosis is attributed to the preparation or consumption of contaminated raw or undercooked pork" - "The same serotypes and genotypes predominate in swine and human infections" - "Yersiniosis has been the third to fourth most frequent zoonosis in the European Union"
This is a well-documented major foodborne pathogen with swine as the primary reservoir.
2. Non-Foodborne Zoonotic Transmission
Level: No non-foodborne zoonotic transmission
Human infection is foodborne: - "Most cases are foodborne and associated with the preparation or consumption of undercooked pork" - The regional US association with "chitterlings" preparation underscores the foodborne route - No direct contact transmission from swine is described
3. Beyond-Farm Spread Potential
Level: Spreads despite standard measures
The organism is widespread and difficult to exclude: - "Yersinia enterocolitica can be isolated from a wide variety of mammals and birds" - "It can also be detected in the environment, including ponds and lakes" - Farm prevalence is very high: 32-53% of US farms, up to 100% on some European farms - "Factors known to increase the risk for farm infection are the purchase of swine from outside sources, feeding of animal protein products, and use of surface or shallow-well water sources"
The high baseline prevalence and environmental persistence make exclusion difficult despite biosecurity measures.
4. Detection Difficulty
Level: Straightforward detection
Laboratory detection is straightforward though requires appropriate methods: - "Yersinia enterocolitica and Y. pseudotuberculosis can readily be isolated at 37°C on blood and MacConkey agar from tissues with lesions" - "Most isolation methods for Yersinia use cold enrichment techniques"
The organism grows readily on standard media. The main complexity is that pigs are asymptomatic carriers, making detection dependent on active surveillance rather than clinical presentation.
5. Financial Impact - Mortality and Morbidity Costs
Level: Minimal losses
Y. enterocolitica does not cause clinical disease in commercial swine: - "Enteropathogenic Y. enterocolitica and Y. pseudotuberculosis do not generally cause clinical disease in pigs on commercial swine farms" - "In general, swine are considered asymptomatic carriers of Campylobacter under natural settings" [analogous statement for Yersinia] - Colonization studies in 11-24 week old pigs showed "colonization and fecal shedding, but no clinical disease"
There are no production losses because swine experience no disease from carriage.
6. Financial Impact - Prevention and Control Costs
Level: Little market disruption
Yersiniosis is a food safety rather than live animal concern: - No live animal testing or trade restrictions - No slaughter surveillance triggering condemnation - "Control of foodborne disease is best accomplished in the slaughter plant... and in the home with appropriate sanitation during food preparation"
The cost is borne by public health systems and consumers, not swine producers.
7. Antimicrobial Resistance - Pathogen Risk
Level: No AMR concern
No AMR concerns are described for Y. enterocolitica in swine. The chapter does not mention resistance issues or the organism as a resistance reservoir. Human treatment is typically not required as disease is usually self-limiting.
8. Antimicrobial Resistance - Treatment Impact
Level: Minimal AMR concern from disease management
Swine are not treated for Y. enterocolitica carriage: - "Absent clinical disease, Yersinia infections in swine are rarely treated, prevented, or otherwise controlled"
No antimicrobial selection pressure occurs in swine because no treatment is administered.
9. Treatment Availability
Level: Highly effective treatments readily available
While swine are not treated, the organism is susceptible: - The chapter does not describe any resistance concerns - Standard antibiotics are effective when needed for experimental models
The "highly effective" designation reflects the absence of any treatment limitations.
10. Vaccine Availability
Level: No effective vaccine
No vaccine is mentioned. Given that swine experience no disease, there is no target for vaccination. Prevention focuses on food safety measures rather than farm-level immunization.
11. Eradication Feasibility
Level: Not feasible to eradicate
The organism is ubiquitous: - "Can be isolated from a wide variety of mammals and birds" - "Can also be detected in the environment, including ponds and lakes" - Farm prevalence commonly exceeds 50% - "Considering the ubiquitous nature of Y. enterocolitica in the farm environment and swine herds, prevention or control at the preharvest level would be extremely challenging"
Environmental persistence, wildlife reservoirs, and high baseline prevalence make eradication impossible.
Summary
Yersinia enterocolitica is asymptomatically carried by swine, which serve as the primary reservoir for human yersiniosis - the third to fourth most common zoonosis in the EU. Approximately 75% of human cases are attributed to contaminated pork consumption. Critically, the organism causes no clinical disease in commercial swine, creating no production losses and no treatment requirements. The high prevalence (often 50-100% of farms) and environmental persistence make preharvest control impractical. Food safety intervention focuses on slaughter plant hygiene and consumer food handling rather than on-farm measures. This represents a pure food safety concern with no animal health impact.